Status:

COMPLETED

Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation

Lead Sponsor:

SPD Development Company Limited

Conditions:

Ovulation

Eligibility:

FEMALE

18-40 years

Brief Summary

This study will examine the performance of the Persona assays in identifying the time when risk of pregnancy is highest by comparing results to ultrasound observed ovulation and other indices of ovula...

Detailed Description

Persona is a CE marked, natural method of contraception that works by monitoring hormone changes in a woman's urine to identify the days of her menstrual cycle when she is likely to become pregnant fo...

Eligibility Criteria

Inclusion

  • Female
  • Aged 18 - 40 years
  • Menstrual cycle length between 23 and 35 days
  • Had two natural cycles prior to study participation
  • Using non-hormonal contraception to avoid pregnancy OR abstaining from intercourse for the last three months and the present cycle
  • N.B: Non hormonal contraception includes barrier methods such as male and female condoms, diaphragms or caps, non-hormonal intra-uterine devices such as coils, male and female sterilisation or natural family planning

Exclusion

  • Unwilling to provide written informed consent to participate in the study or comply with study procedures
  • Pregnant
  • Breastfeeding
  • Has menopausal symptoms such as night sweats or hot flushes
  • Using any hormonal treatments e.g. hormonal contraception, fertility treatments and hormone replacement therapy (except thyroxin)
  • Taking antibiotics (based on decision by principle investigator)
  • Has a diagnosis of polycystic ovarian syndrome (PCOS)
  • Has impaired liver or kidney function
  • Intending to use PERSONA as a contraceptive during the study period
  • Contraindications to frequent blood sampling e.g. anaemia, hypotonia and blood clotting diseases
  • Contraindications to frequent ultrasound examinations e.g. morbid obesity and recent abdominal surgery

Key Trial Info

Start Date :

February 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2013

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT01802060

Start Date

February 1 2013

End Date

November 1 2013

Last Update

December 2 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Green-ivf, Rheydter Strasse 143, Grevenboich

Düsseldorf, Germany, 41515